MDPV

MDPV
Chemical Nomenclature
Common names	3,4-Methylenedioxypyrovalerone
Substitutive name	MDPV
Systematic name	(RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
Routes of Administration
WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section. ⇣ Smoked Dosage Bioavailability n/a Threshold < 1 mg Light 1 - 2 mg Common 2 - 5 mg Strong 5 - 10 mg Heavy > 10 mg Duration Total 4 - 6 hours Onset 10 seconds Peak 1 minute Offset 3 hours ⇣ Oral Dosage Bioavailability n/a Threshold < 1 mg Light 1 - 2 mg Common 2 - 5 mg Strong 5 - 1 mg Heavy > 10 mg Duration Total 8 - 12 hours Onset 30 minutes Peak 2 hours Offset 10 hours ⇣ Insufflated Dosage Bioavailability n/a Threshold < 1 mg Light 1 - 2 mg Common 2 - 5 mg Strong 5 - 10 mg Heavy 5 - 10 mg Duration [[ {{{InsufflatedROA_TimelineFile}}} | center | {{{InsufflatedROA_TimelineWidth}}} ]] Total 5 - 12 hours Onset 1 min Peak 10 min Offset 5 hours DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.
Interactions

Methylenedioxypyrovalerone (MDPV) is a psychoactive recreational drug with stimulant properties which acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004 when it was reportedly sold as a designer drug. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing for Spice and K2 as incense.

Incidents of psychological and physical harm have been attributed to MDPV use.